Literature DB >> 11602631

Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.

C Nataraj1, D W Thomas, S L Tilley, M T Nguyen, R Mannon, B H Koller, T M Coffman.   

Abstract

Production of prostaglandin E(2) (PGE(2)) is enhanced during inflammation, and this lipid mediator can dramatically modulate immune responses. There are four receptors for PGE(2) (EP1-EP4) with unique patterns of expression and different coupling to intracellular signaling pathways. To identify the EP receptors that regulate cellular immune responses, we used mouse lines in which the genes encoding each of the four EP receptors were disrupted by gene targeting. Using the mixed lymphocyte response (MLR) as a model cellular immune response, we confirmed that PGE(2) has potent antiproliferative effects on wild-type responder cells. The absence of either the EP1 or EP3 receptors did not alter the inhibitory response to PGE(2) in the MLR. In contrast, when responder cells lacked the EP2 receptor, PGE(2) had little effect on proliferation. Modest resistance to PGE(2) was also observed in EP4-/- responder cells. Reconstitution experiments suggest that EP2 receptors primarily inhibit the MLR through direct actions on T cells. Furthermore, PGE(2) modulates macrophage function by activating the EP4 receptor and thereby inhibiting cytokine release. Thus, PGE(2) regulates cellular immune responses through distinct EP receptors on different immune cell populations: EP2 receptors directly inhibit T cell proliferation while EP2 and EP4 receptors regulate antigen presenting cells functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602631      PMCID: PMC209534          DOI: 10.1172/JCI13640

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic liver transplantation.

Authors:  S Tancharoen; R M Jones; P W Angus; K J Hardy
Journal:  Transplant Proc       Date:  1993-10       Impact factor: 1.066

2.  Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE.

Authors:  R L Roper; D M Brown; R P Phipps
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

3.  Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response.

Authors:  P J Christensen; M W Rolfe; T J Standiford; M D Burdick; G B Toews; R M Strieter
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

Review 4.  Prostanoid biosynthesis and mechanisms of action.

Authors:  W L Smith
Journal:  Am J Physiol       Date:  1992-08

5.  Intragraft delivery of 16, 16-dimethyl PGE2 induces donor-specific tolerance in rat cardiac allograft recipients.

Authors:  T Kamei; M P Callery; M W Flye
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

6.  A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation.

Authors:  K S Henley; M R Lucey; D P Normolle; R M Merion; I D McLaren; B A Crider; D S Mackie; V L Shieck; T T Nostrant; K A Brown
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

7.  Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts.

Authors:  E J Goetzl; S An; L Zeng
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

8.  The effects of 16, 16 dimethyl prostaglandin E2 therapy alone and in combination with low-dose cyclosporine on rat small intestinal transplantation.

Authors:  I H Koh; P C Kim; S W Chung; T Waddell; P Y Wong; R Gorczynski; G A Levy; Z Cohen
Journal:  Transplantation       Date:  1992-10       Impact factor: 4.939

9.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.

Authors:  T C van der Pouw Kraan; L C Boeije; R J Smeenk; J Wijdenes; L A Aarden
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.

Authors:  F Paliogianni; R L Kincaid; D T Boumpas
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  102 in total

1.  Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties.

Authors:  Carlo José F Oliveira; Anderson Sá-Nunes; Ivo M B Francischetti; Vanessa Carregaro; Elen Anatriello; João S Silva; Isabel K F de Miranda Santos; José M C Ribeiro; Beatriz R Ferreira
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

Review 2.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity.

Authors:  G Y Park; N Hu; X Wang; R T Sadikot; F E Yull; M Joo; R S Peebles; T S Blackwell; J W Christman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

4.  Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling.

Authors:  Timothy D Bryson; Jacob Ross; Edward Peterson; Pamela Harding
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-06-20       Impact factor: 3.072

5.  Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.

Authors:  Jia Liu; Atsushi Kuwabara; Yoshinobu Kamio; Shuling Hu; Jeonghyun Park; Tomoki Hashimoto; Jae-Woo Lee
Journal:  Stem Cells       Date:  2016-07-08       Impact factor: 6.277

6.  An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice.

Authors:  Vandana Kaul; Debapriya Bhattacharya; Yogesh Singh; Luc Van Kaer; Marc Peters-Golden; William R Bishai; Gobardhan Das
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

Review 7.  Prostanoids and inflammation: a new concept arising from receptor knockout mice.

Authors:  Shuh Narumiya
Journal:  J Mol Med (Berl)       Date:  2009-07-17       Impact factor: 4.599

8.  Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway.

Authors:  Kasturi Ganesh; Amitava Das; Ryan Dickerson; Savita Khanna; Narasimham L Parinandi; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Skin tight: macrophage-specific COX-2 induction links salt handling in kidney and skin.

Authors:  Johannes Stegbauer; Thomas M Coffman
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

10.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.

Authors:  Jennifer M McCoy; Joan R Wicks; Laurent P Audoly
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.